# Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery

> **NCT01954732** · PHASE1 · WITHDRAWN · sponsor: **Case Comprehensive Cancer Center**

## Conditions studied

- Stage IA Pancreatic Cancer
- Stage IB Pancreatic Cancer
- Stage IIA Pancreatic Cancer
- Stage IIB Pancreatic Cancer

## Interventions

- **DRUG:** metformin hydrochloride
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT01954732
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2015-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01954732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01954732, "Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01954732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*